Inter Partes Review Of Patented Anti-Diabetic Medication Requested

(December 20, 2019, 1:01 PM EST) -- ALEXANDRIA, Va. — A patent used in three Novo Nordisk A/S diabetes drugs would have been obvious to a person of skill in the art (POSA), a petitioner for inter partes...
To view the full article, register now.